_____________ bill NO. _____________

INTRODUCED BY _________________________________________________

By Request of the ****

A BILL FOR AN ACT ENTITLED: "AN ACT REVISING IMMUNIZATION REQUIREMENTS FOR PHARMACISTS; PROVIDING THAT PHARMACISTS, INTERNS, AND PHARMACY TECHNICIANS MAY ADMINISTER ROUTINE IMMUNIZATIONS OR COVID-19 IMMUNIZATIONS TO INDIVIDUALS 3 YEARS OF AGE OR OLDER; AMENDING SECTION 37-7-105, MCA; and PROVIDING AN immediate EFFECTIVE DATE."

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:

Section 1. Section 37-7-105, MCA, is amended to read:

"37-7-105. Administration of immunizations. (1) An immunization-certified pharmacist may:

(a) prescribe and administer the following immunizations without a collaborative pharmacy practice agreement in place:

(i) influenza to individuals who are 12 years of age or older;

(ii) pneumococcal, tetanus, diptheria, and pertussis to individuals who are 18 years of age or older; and

(iii) herpes zoster to those individuals identified in the guidelines published by the United States centers for disease control and prevention's advisory committee on immunization practices; and

(b) administer immunizations to individuals 7 years of age or older as provided by the most recent guidelines by vaccine and age group published by the United States centers for disease control and prevention and as determined within a collaborative practice agreement

(a) immunizations to individuals 3 years of age or older in accordance with the United States centers for disease control and prevention's advisory committee on immunization practices' standard immunization schedule; and

(b) immunizations approved, licensed, or granted emergency use authorization by the FDA to persons 3 years of age or older in accordance with the United States centers for disease control and prevention's advisory committee on immunization practices' immunization recommendations and in compliance with requirements under the United States centers for disease control and prevention's immunization provider agreement and any other federal requirements applicable to the administration of immunizations.

(2) In the event of an adverse reaction, a pharmacist may administer epinephrine or diphenhydramine to:

(a) an individual who is 12 years of age or older; and

(b) a child who is 7 years of age or older and under 12 years of age within a collaborative practice agreement an individual who is 3 years of age or older.

(3) If a pharmacist provides an immunization that is part of a series requiring multiple doses over time, the pharmacist shall notify the individual or the individual's legal representative at the time the next immunization in the series is due to be administered by sending a notice to the individual or representative that the followup immunization is needed to fulfill the series requirement.

(4) A pharmacist who administers an immunization pursuant to this section shall:

(a) ensure that the individual who is being immunized is assessed for contraindications to immunization;

(b) ensure that the individual who is being immunized or the individual's legal representative receives a copy of the appropriate vaccine information statement;

(i) the patient's primary health care provider, if the patient identifies one; and

(ii) the medical provider or providers with whom the pharmacist has a collaborative practice agreement; and

(iii)(ii) the vaccine adverse event reporting system established under the United States department of health and human services;

(d) provide a signed certificate of immunization to the primary health care provider, if known, of each individual who is immunized and to the individual who is immunized that includes the individual's name, date of immunization, address of immunization, administering pharmacist, immunization agent, manufacturer, and lot number;

(e) create a record for each immunization, in which the individual's name, date, address of immunization, administering pharmacist, immunization agent, manufacturer, and lot number are included, and maintain the record for 7 years from the date the immunization was administered or until 7 years after the individual reaches 18 years of age, whichever is later; and

(f) offer the patient the opportunity to have the immunization information reported to the state immunization information system.

(5) A pharmacist who administers an immunization identified under subsection (1)(a) to a patient who is under 18 years of age shall inform the patient and the patient's adult caregiver of the importance of a well-child visit with a pediatrician or other licensed primary care provider and shall refer the patient as appropriate.

(6) A pharmacist may not delegate to another person the administration of immunizations authorized under this section, except:

(a) under the direct supervision and with the authorization of the pharmacist, to a licensed intern who has completed a practical training program that is approved by the accreditation council for pharmacy education or the board and that includes instruction in hands-on injection technique, clinical evaluation of indications and contraindications of immunizations, and the recognition and treatment of emergency reactions to vaccines and who holds a current basic cardiopulmonary resuscitation certification; or

(b) under an approved utilization plan and under the direct supervision and with the authorization of the pharmacist, to a pharmacy technician who has completed a practical training program that is approved by the accreditation council for pharmacy education or the board and that includes instruction in hands-on injection technique, clinical evaluation of indications and contraindications of immunizations, and the recognition and treatment of emergency reactions to vaccines and who holds a current basic cardiopulmonary resuscitation certification.

(5)(7) For the purposes of this section, "vaccine information statement" means an information sheet that is produced by the United States centers for disease control and prevention that explains the benefits and risks associated with a vaccine to a vaccine recipient or the legal representative of the vaccine recipient."

NEW SECTION. Section 2. Effective date. [This act] is effective on passage and approval.